Cargando…
Hepatitis B Therapeutic Vaccine: A Patent Review
Viral hepatitis has long been underrated as a danger to global health. The UN only recently called for worldwide action to tackle viral hepatitis and lessen the disease burden in its “2030 Agenda for Sustainable Development”. Hepatitis B virus (HBV), which causes liver cirrhosis and malignancy, is a...
Autores principales: | Hudu, Shuaibu Abdullahi, Jimoh, Abdulgafar Olayiwola, Ibrahim, Kasimu Ghandi, Alshrari, Ahmed Subeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783911/ https://www.ncbi.nlm.nih.gov/pubmed/36558991 http://dx.doi.org/10.3390/ph15121542 |
Ejemplares similares
-
Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2013) -
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects
por: Alshrari, Ahmed S., et al.
Publicado: (2023) -
Innovations and development of Covid-19 vaccines: A patent review
por: Alshrari, Ahmed S., et al.
Publicado: (2022) -
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions
por: Hudu, Shuaibu A., et al.
Publicado: (2023) -
Antibody and immune memory persistence post infant hepatitis B vaccination
por: Hudu, Shuaibu A, et al.
Publicado: (2013)